IGFBP3 and breast carcinoma: Generally, our findings are consistent with previous studies, demonstrating the role of exogenous IGFBP3 as a mediator doxorubicin-induced senescence of breast cancer cells [23], as well as replicative senescence of umbilical vein endothelial cells [21, 61].